- Home
- FLWS vs EDIT Comparison
FLWS vs EDIT Comparison
Compare FLWS & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- EDIT
- Stock Information
- Founded
- FLWS 1976
- EDIT 2013
- Country
- FLWS United States
- EDIT United States
- Employees
- FLWS N/A
- EDIT N/A
- Industry
- FLWS Other Specialty Stores
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLWS Consumer Discretionary
- EDIT Health Care
- Exchange
- FLWS Nasdaq
- EDIT Nasdaq
- Market Cap
- FLWS 268.5M
- EDIT 269.8M
- IPO Year
- FLWS 1999
- EDIT 2016
- Fundamental
- Price
- FLWS $4.54
- EDIT $3.69
- Analyst Decision
- FLWS Hold
- EDIT Buy
- Analyst Count
- FLWS 1
- EDIT 11
- Target Price
- FLWS $7.50
- EDIT $4.56
- AVG Volume (30 Days)
- FLWS 505.3K
- EDIT 3.4M
- Earning Date
- FLWS 10-30-2025
- EDIT 11-03-2025
- Dividend Yield
- FLWS N/A
- EDIT N/A
- EPS Growth
- FLWS N/A
- EDIT N/A
- EPS
- FLWS N/A
- EDIT N/A
- Revenue
- FLWS $1,685,658,000.00
- EDIT $38,901,000.00
- Revenue This Year
- FLWS N/A
- EDIT N/A
- Revenue Next Year
- FLWS $0.99
- EDIT N/A
- P/E Ratio
- FLWS N/A
- EDIT N/A
- Revenue Growth
- FLWS N/A
- EDIT N/A
- 52 Week Low
- FLWS $3.86
- EDIT $0.91
- 52 Week High
- FLWS $9.24
- EDIT $4.54
- Technical
- Relative Strength Index (RSI)
- FLWS 41.94
- EDIT 54.45
- Support Level
- FLWS $4.18
- EDIT $3.32
- Resistance Level
- FLWS $4.63
- EDIT $4.33
- Average True Range (ATR)
- FLWS 0.20
- EDIT 0.37
- MACD
- FLWS 0.02
- EDIT -0.03
- Stochastic Oscillator
- FLWS 47.79
- EDIT 30.40
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.